Virology

<a href="https://www.bioagilytix.com/blog/category/virology/">Virology</a>

Plaque Reduction Neutralization Tests (PRNT) and the Development of New Antiviral Drugs

  • July 1, 2022

While infectious disease has always been an important area of scientific and medical research, the recent pandemic has brought this discipline more clearly into the…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/vaccines/">Vaccines</a>

The Broad Array of Vaccine Options for COVID-19

  • May 4, 2022

As we pass the two-year anniversary of the start of the coronavirus pandemic, we are reminded of where we started and how far we have…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/gene-therapy/">Gene Therapy</a>

Validation of qPCR Assays for Gene Therapy

  • January 27, 2022

Though the modern world has progressed a lot in terms of medical interventions and biomedicine, there still are a vast number of diseases and disorders…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/gene-therapy/">Gene Therapy</a>

Challenges for Measuring Immunogenicity of AAV-based Gene Therapies

  • September 15, 2021

Gene therapy is a powerful form of treatment that involves introducing genetic material into cells to replace defective genes resulting in the production of an…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/gene-therapy/">Gene Therapy</a>

Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials

  • July 23, 2020

The concept of using pre-existing immunogenicity as an exclusion criteria for gene therapy clinical trials is changing. BioAgilytix’s Chief Scientific Officer, Dr. Jim McNally, explores…

Find Out More